ArticleScientific reports2024

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.

Gongxun Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.